Loading…
for educational and safety purposes
Dronabinol and Nabilone both come up in the same conversations; they overlap on Appetite and Nausea. Dronabinol: Dronabinol is a pharmaceutical cannabinoid that consists of synthetically produced (-)-trans-delta-9-tetrahydrocannabinol (delta-9-THC), the principal psychoactive constituent of Cannabis sativa, formulated as an oral agent. Nabilone: Nabilone is a synthetic cannabinoid (a structural analog of delta-9-tetrahydrocannabinol) that acts as an agonist at the cannabinoid CB1 and CB2 receptors.
Dronabinol is a pharmaceutical cannabinoid that consists of synthetically produced (-)-trans-delta-9-tetrahydrocannabinol (delta-9-THC), the principal psychoactive constituent of Cannabis sativa, formulated as an oral agent. Marketed as Marinol (sesame-oil capsules) and Syndros (an oral solution), it is approved by the U.S. FDA for chemotherapy-induced nausea and vomiting refractory to conventional antiemetics and for anorexia associated with weight loss in patients with AIDS. It acts as a partial agonist at the CB1 and CB2 cannabinoid receptors of the endocannabinoid system, producing appetite stimulation, antiemetic effects, analgesia, and mood elevation. Dronabinol capsules were rescheduled from Schedule II to the less restrictive Schedule III in the United States, while the Syndros oral solution remains Schedule II.
Nabilone is a synthetic cannabinoid (a structural analog of delta-9-tetrahydrocannabinol) that acts as an agonist at the cannabinoid CB1 and CB2 receptors. Marketed as Cesamet, it is approved in the United States, Canada, the United Kingdom and other countries for the treatment of severe nausea and vomiting associated with cancer chemotherapy that has failed to respond to conventional antiemetics. Unlike inhaled cannabis or plant-derived THC, nabilone is a single, orally administered, pharmaceutically standardized molecule, which gives it consistent dosing and a defined pharmacokinetic profile. Beyond its licensed antiemetic indication, it has been studied off-label for neuropathic and chronic non-cancer pain, fibromyalgia, PTSD-associated nightmares, and agitation in Alzheimer's disease, with mixed but frequently encouraging results. Nabilone is a Schedule II controlled substance in the United States and a prescription-only medicine.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
Partial agonist
agonist
Partial agonist
agonist
Inhibits
Negative allosteric modulator
suppresses
modulates (downregulates)
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.